Head-to-head · Cost-Efficiency Index
Luvo Health vs ARSYNL Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Luvo Health
Shoppers who want to read a complete, un-gated price list — compounded and brand, injection and tablet, at four commitment lengths — and who will do the four-week arithmetic before comparing it with a monthly rate.
Visit Luvo HealthARSYNL Rx
Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Visit ARSYNL RxThe verdict
ARSYNL Rx takes it, leading the Cost-Efficiency Index 56 to 54. ARSYNL Rx is a veteran-founded (Arron Glysch) telehealth platform selling compounded semaglutide ($233/mo) and tirzepatide, either as a standard injectable ($233/mo) or a needle-free HypoSpray with six dose protocols (from $256.33/mo). Luvo Health still earns a C — Shoppers who want to read a complete, un-gated price list — compounded and brand, injection and tablet, at four commitment lengths — and who will do the four-week arithmetic before comparing it with a monthly rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs ARSYNL Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Luvo Health | ARSYNL Rx |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 56/100 |
| Semaglutide / mo | $249 per 4 weeks (injection, compounded) | $233/mo (starting dose, compounded) |
| Tirzepatide / mo | $339 per 4 weeks (injection, compounded) | $233/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,988 | $2,796 |
| Tirzepatide / yr (modeled) | $4,068 | $2,796 |
| Coverage | Not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #318 | #320 |
Luvo Health
54/100Where the value is
- The whole price list is public and server-rendered at /pricing — 156 rows, every medication, both forms and all four commitment lengths — before any intake, quiz, login or email capture
- Both molecules and both routes are priced: semaglutide injection $249, semaglutide tablets $279 and tirzepatide injection $339 per 4 weeks, with no separate membership or visit line item on the price table
- Real brand-name access with real prices — Ozempic® $1,299 and Zepbound® $1,399 per 4 weeks — rather than a brand logo with no purchasable figure behind it
The tradeoffs
- Prices are billed every FOUR WEEKS, not monthly, so thirteen charges fall in a calendar year rather than twelve — this page's modeled 12-month figure is twelve four-week periods, which is 48 weeks, and the real annual cost is one period higher
- Two pages headline "Starting at $45/week", which is the 52-week prepay rate divided out — the weight-loss page discloses that it is billed annually and the medication page does not, so the same number is honest on one page and not on the other
ARSYNL Rx
56/100Where the value is
- Genuinely veteran-founded — the About page names founder Arron Glysch and recounts his own hair-loss experience while deployed overseas
- Offers a needle-free tirzepatide HypoSpray with six published dose protocols (10mg-60mg total/month)
- All three GLP-1 SKUs are stated to already include the consultation and shipping in the quoted price
The tradeoffs
- No compounding pharmacy is named on any product page checked
- No individual medical director or prescriber is named anywhere accessible — only 'U.S. board certified physicians' as a category
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.